Kathmere Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $243K | Sell |
|
|||||
|
2025
Q2 | $428K | Sell |
|
|||||
|
2025
Q1 | $584K | Sell |
|
|||||
|
2024
Q4 | $602K | Buy |
|
|||||
|
2024
Q3 | $413K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $222K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $229K | Buy |
|
|||||
|
2023
Q1 | $243K | Sell |
|
|||||
|
2022
Q4 | $322K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $157K | Hold |
|
|||||
|
2020
Q3 | $153K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $379K | Buy |
|